Company Name, Ticker, Competitors, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
ATRA's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Atara Biotherapeutics Inc News
Atara Biotherapeutics Inc's Price to Cash Flow ratio
Atara Biotherapeutics Inc's Revenue Growth
Atara Biotherapeutics Inc Business Description
Atara Biotherapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Atara Biotherapeutics Inc Growth Rates
Atara Biotherapeutics Inc Profitability
Atara Biotherapeutics Inc Valuation
Atara Biotherapeutics Inc Management Effectiveness
Atara Biotherapeutics Inc Financial Strength
Atara Biotherapeutics Inc Efficiency
Atara Biotherapeutics Inc Dividend
Financials
Atara Biotherapeutics Inc Business Segments
Atara Biotherapeutics Inc Income Statement
Atara Biotherapeutics Inc Balance Sheets
Atara Biotherapeutics Inc Cash Flow Statement
Atara Biotherapeutics Inc Geographic Information
Suppliers
Atara Biotherapeutics Inc Suppliers Performance
ATRA Suppliers Stock Performance
ATRA Suppliers Growth Rates
ATRA Suppliers Data
ATRA Suppliers Efficiency
ATRA Suppliers Management Effectiveness
ATRA Suppliers Valuation
ATRA Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Atara Biotherapeutics Inc Market Share
Atara Biotherapeutics Inc Competition Performance
Atara Biotherapeutics Inc Competitors Results
ATRA Competitors Stock Performance
ATRA Competitors Growth Rates
ATRA Workforce Efficiency at the Competitors
ATRA Competitors Efficiency
ATRA Competitors Management Effectiveness
ATRA Competitors Valuation
Customers & Markets
Atara Biotherapeutics Inc Customers Demand
ATRA Customers Expenditure Growth Rates
ATRA Customers Performance
ATRA Customers Stock Performance
ATRA Customers Growth Rates
ATRA Workforce Efficiency at the Customers
ATRA Customers Efficiency
ATRA Customers Management Effectiveness
ATRA Customers Valuation
ATRA Customers by Companys' Segments
Charts & Quotes
Atara Biotherapeutics Inc Comparison Charts
ATRA OHLC Charts
ATRA's Tehnical Upper Indicators
ATRA's Tehnical Lower Indicators
ATRA's Weekly Charts
ATRA's Monthly Charts
Atara Biotherapeutics Inc's Profile
Company Charts and Quotes
Atara Biotherapeutics Inc News
Atara Biotherapeutics Inc's Geographic Information
Atara Biotherapeutics Inc's Income Statement
Atara Biotherapeutics Inc's Balance Sheets
Atara Biotherapeutics Inc's Cash Flow Statement
Atara Biotherapeutics Inc's Profitability
Atara Biotherapeutics Inc's Financials
Atara Biotherapeutics Inc's Revenue Y/Y
Atara Biotherapeutics Inc's Suppliers
Atara Biotherapeutics Inc's Competitors
Atara Biotherapeutics Inc's Markets & Customers
Atara Biotherapeutics Inc's Market Share
ATRA's Suppliers Efficiency
ATRA's Competitors Management Effectiveness
ATRA's Charts Keltner Channels (KC)
ATRA's Customers Demand
Economic Indicators
Net Income Growth by Industry
Growth Rates Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Housing Starts
News
Economy News
Stock News
About Us
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Atara Biotherapeutics Inc
(
ATRA
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Biotechnology & Pharmaceuticals
Industry
•
Biotechnology & Pharmaceuticals
Sector
•
Healthcare
Atara Biotherapeutics Inc 's Yearly Income from Continued Operations Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
ATRA Annual Income from Cont. Operations Growth
2022
2021
2019
2018
2017
Y / Y Annual Income from Cont. Operations Change
-
-
-
-
-
Annual Income from Cont. Operations (in millions $)
$-228.30
$-340.14
$-290.98
$-230.70
$-119.49
ATRA Company Profile
>>
Back to ATRA Fundamentals at a Glance
>>
Back to ATRA Growth Comparisons
Annual Income from Cont. Operations Growth Comment
Atara Biotherapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2022 Annual Income from Cont. Operations within Healthcare Sector
Y/Y Income from Continued Operations Growth %
2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd
-99.39 %
$ 88.131 millions
Koninklijke Philips Nv